AKT1 and diabetes mellitus: Diabetes is also linked to lower plasma levels of adiponectin, which blocks adenosine monophosphate‐activated protein kinase (AMPK) and activates the Akt (protein kinases B) and ERK paths, raising the risk of cancer (Sun & Kashyap, 2011).